Statins,platelets,and the elderly
Statins, platelets, and the elderly
摘要
As a class of drugs, statins have gained renown for their ability to effectively reduce cardiovascular events in both patients with heart diseases (secondary prevention)and in those who, while not with manifest heart disease (primary prevention), are at increased risk based on a variety of risk factors including hypertension, diabetes, and age.……
二级参考文献11
-
1[1]Scandinavian Simvastatin Survival Study Group.Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease:the Scandinavian Simvastatin Survival Study (4S).Lancet 1994;344:1383-9.
-
2[2]West of Scotland Coronary Prevention Study Group.Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.N Engl J Med 1995; 333:1301-7.
-
3[3]Editorial Board of Chinese Journal of Cardiology.Recommendations to prevent dyslipidemia.Zhonghua Xin Xue Guan Bing Za Zhi 1997;25:169-75 (in Chinese).
-
4[4]Aviram M,Osamash H,Mira R.Interactions of platelets,macrophages,and lipoproteins in hypercholesterolemia:antiatherogenic effects of HMG-CoA reductase inhibitor therapy.J Cardiovasc Pharmacol 1998;31:34839-45.
-
5[5]Schultheiss HP,Tschoepe D,Esser J,et al.Large platelets continue to circulate in an activated state after myocarydial infarction.Eur J Clin Invest 1994;24:243-7.
-
6[6]Peerschke EI.Adhesive protein expression on thrombinstimulated platelets:time-dependent modulation of antifibrinogen,fibronectin and yon Willebrand factor antibody binding.Blood 1992;79:948-53.
-
7[7]Lipid Research Clinics Program.The lipids clinics coronary primary prevention trial results the relationship of reduction in incidence of coronary heart disease to cholesterol lowing.JAMA 1984;251:356-74.
-
8[8]Galle JE,Bassenge R.Oxidized low density lipoprotein potentiate vasoconstrictions to various agonists by direct interaction with vascular smooth muscle.Cir Res 1990;66:1287-93.
-
9[9]Horio T,Kohno M,Murukawa K,et al.Increased plasma immunoreactive endothelin concentration in hypercholesterolemic rats.Atherosclerosis 1999; 89:239-46.
-
10[10]Tschoepe D,Driesch E,Schwippert B,et al.Activated platelets in subjects at increased risk of IDDM.Diabetologia 1997;40:573-7.
-
1Christos Triantos,Maria Kalafateli.Primary prevention of bleeding from esophageal varices in patients with liver cirrhosis[J].World Journal of Hepatology,2014,6(6):363-369. 被引量：6
-
2Bharti Chogtu,Rahul Magazine,KL Bairy.Statin use and risk of diabetes mellitus[J].World Journal of Diabetes,2015,6(2):352-357. 被引量：8
-
3Mehmet Ali Eren,Tevfik Sabuncu,Hüseyin Karaaslan.Comment on: Statin use and risk of diabetes mellitus[J].World Journal of Diabetes,2016,7(8):175-176. 被引量：2
-
4韩秀霞.他汀类药物可降低卒中危险[J].国外医学情报,1998(9):22-22.
-
5What are the effects of proton pump inhibitors on the smallintestine？[J].World Journal of Gastroenterology,2015,21(22):6820-6834.
-
6Meng-Hsuan Cheng,Hui-Fen Chiu,Shu-Chen Ho,Shang-Shyue Tsai,Trong-Neng Wu,Chun-Yuh Yang.Statin use and the risk of colorectal cancer: A population-based case-control study[J].World Journal of Gastroenterology,2011,17(47):5197-5202. 被引量：4
-
7徐铮奎.“他汀”类药物可预防冠心病发作[J].开卷有益（求医问药）,2001(6):27-27.
-
8Wei Zhu,Chi Xu,Bu-Peng Ma,Zhi-Bo Zheng,Yu-Long Li,Qi Ma,Guo-Liang Wu,Xi-Sheng Weng.Three-dimensional Printed Scaffolds with Gelatin and Platelets Enhance In vitro Preosteoblast Growth Behavior and the Sustained-release Effect of Growth Factors[J].Chinese Medical Journal,2016(21):2576-2581. 被引量：5
-
9Wilbert S. Aronow.Medical treatment of peripheral arterial disease in the elderly[J].Journal of Geriatric Cardiology,2007,4(2):93-100.
